Rx-to-OTC Switch Pipelines USA

United States Lags Behind Other Nations in Rx-to-OTC Switch Approvals

In contrast to the U.S. FDA, regulatory agencies outside the United States have been much more aggressive in approving switches for conditions outside the typical OTC paradigm. The United Kingdom in particular takes pride in being at the forefront of switching. U.K. Pharmacy Minister Earl Howe has continually stressed that increasing patient choice by making more medicines available without a prescription is a priority for the British government. When speaking at the Proprietary Association of Great Britain conference in London on July 5, 2012, he stated, “The United Kingdom leads the world in the range of products available without a prescription—but more can always be done.” Continue reading